What does CUSIP 00211Y407 represent in this 13F holders report?

CUSIP 00211Y407 is the security identifier for ABIO - ARCA BIOPHARMA INC - COM PAR$.001 used to aggregate holder disclosures.

How many institutions held ABIO - ARCA BIOPHARMA INC - COM PAR$.001 in Q2 2017?

12 institutional investors reported ABIO - ARCA BIOPHARMA INC - COM PAR$.001 for Q2 2017. Use the holders table for investor-level position and value details.

ARCA BIOPHARMA INC - COM PAR$.001 (ABIO)

CUSIP: 00211Y407

Q2 2017 13F Holders as of 30 Jun 2017

Security type / class: Equity / COM PAR$.001
Total 13F shares: 3,987,261
Total 13F value: $9,683,000
Share change: +166,819
SEC-reported price per share: $2.40
Number of holders: 12
Value change: +$406,877
Number of buys: 4
Number of sells: 3

Security key

00211Y407

Report period

Q2 2017

Institutions

Top holders

ABIO full security history Ownership snapshot Full 13F holder table Oruka Therapeutics, Inc. SEC filings Oruka Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ABIO - ARCA BIOPHARMA INC - COM PAR$.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

NEA Management Company, LLC

Disclosed value leader

NEA Management Company, LLC

Comparable rows

0/14

Latest evidence

31 Mar 2017

13F Highest disclosed value: $3,724,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

NEA Management Company, LLC has the largest disclosed position value at $3.72M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEA Management Company, LLC's linked filing trail.

Disclosed position value Top 5

NEA Management Company, LLC $3.72M

FRANKLIN TEMPLETON INC $3.04M

VHCP Management II, LLC $2.75M

Tekla Capital Management LLC $2.03M

VANGUARD GROUP INC $304K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
NEA Management Company, LLC	13F Company 13F	— denominator unverified	$3,724,000 1,460,209 shares	—	31 Mar 2017
FRANKLIN TEMPLETON INC	13F Company 13F	— denominator unverified	$3,042,000 1,216,840 shares	—	31 Mar 2017
VHCP Management II, LLC	13F Company 13F	— denominator unverified	$2,751,000 1,078,932 shares	—	31 Mar 2017
Tekla Capital Management LLC	13F Company 13F	— denominator unverified	$2,028,000 811,227 shares	—	31 Mar 2017
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$304,000 121,657 shares	—	31 Mar 2017
Aveo Capital Partners, LLC	13F Company 13F	— denominator unverified	$123,000 48,345 shares	—	31 Mar 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,987,261

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q2 2017 value	Value change	Value Chg %